How Much Weight Should You Lose on Wegovy?

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection activates GLP-1 receptors in your brain to reduce hunger and slow stomach emptying, creating a powerful metabolic shift. Clinical trials show participants lose an average of 15–22% of their starting body weight, but your individual results depend on genetics, adherence, diet quality, and exercise. PlexusDx helps personalize your semaglutide journey with precision dosing—your dose may need to go up, but your price won't.

Typical Weight Loss Results on Semaglutide Injection

The landmark STEP trials, which tested semaglutide for weight loss, followed participants for 68 weeks. Those receiving the highest dose (2.4 mg weekly) lost an average of 14.9 kg, or about 15% of baseline body weight, compared to 2.6 kg in the placebo group. Importantly, weight loss was not immediate—most participants saw meaningful reductions beginning around week 4, with the steepest declines occurring between weeks 8 and 20.

Weight loss on semaglutide is not linear. Many users experience rapid drops in the first 8–12 weeks, then slower but steady progress over months 3–6. By month 4–5, weight loss plateaus for some people, which is a normal physiological adaptation. Continuing the medication past this plateau often produces additional losses, though at a gentler pace.

Starting weight matters significantly. Individuals with a body mass index (BMI) above 35 often see larger absolute weight losses than those with a BMI of 27–30. A person weighing 300 pounds might lose 50–70 pounds, while someone at 200 pounds might lose 30–40 pounds—both representing similar percentage losses but different real-world impacts.

How Genetics Shape Your Semaglutide Response

Your genes control how strongly your GLP-1 receptors respond to semaglutide and how efficiently your body processes hunger signals. Variants in the GLP1R gene (like rs6923761) and the GIPR gene (rs1800437) directly influence receptor sensitivity, meaning two people on identical doses can have very different appetite suppression and weight loss. PlexusDx's Precision Peptide Genetic Test identifies these variants and maps 14 metabolic pathways to predict which compound—semaglutide, tirzepatide, or a dual formula—will work best for your biology.

The FTO gene (rs9939609) and MC4R gene (rs17782313) also affect your baseline hunger drive and how quickly you feel full. Someone with a high-risk FTO variant may need a slightly higher semaglutide dose or additional behavioral support to see the same results as someone with a protective variant. Genetic testing is not required to start semaglutide, but it removes guesswork from treatment optimization, saving you time and money by matching you with the right compound from day one.

Factors That Influence Your Individual Weight Loss

Adherence is the strongest predictor of success. Participants who took semaglutide consistently on schedule lost significantly more weight than those with missed doses. A missed injection creates a dip in blood levels, weakening appetite suppression for that week. PlexusDx's flat monthly pricing ($149 starting) removes cost barriers, making consistent access more sustainable than tier-based programs that penalize higher doses.

Diet quality amplifies semaglutide's effects. While the medication suppresses appetite, eating high-protein, whole-food meals maximizes fullness and preserves lean muscle during weight loss. Conversely, frequent ultra-processed foods can slow progress because they're calorie-dense and less satisfying. Exercise is helpful but not required—the medication does the heavy lifting metabolically, though strength training preserves muscle mass and improves long-term weight stability.

Age, metabolic history, and previous weight loss attempts also play roles. Older adults often lose weight more slowly than younger ones due to natural declines in metabolism. Individuals with a long history of yo-yo dieting may see slower initial results because their bodies adapted to chronic calorie restriction, but semaglutide eventually breaks through this adaptation.

Setting Realistic Expectations and Avoiding Plateaus

Expecting linear weight loss week-to-week is unrealistic and discouraging. Weight naturally fluctuates 2–5 pounds daily due to water retention, food volume, and hormonal cycles. Track progress monthly or every 6 weeks instead of daily. Most people notice clothes fitting better and energy improving before the scale shifts significantly, so non-scale victories matter just as much as pounds lost.

Weight loss plateaus are normal and not a failure. They occur when your body adapts to a lower weight set-point and semaglutide's appetite-suppressing effects stabilize. Plateaus typically last 2–4 weeks and resolve with continued adherence. If a plateau extends beyond 6 weeks with perfect compliance, your doctor may recommend increasing your dose—and with PlexusDx, dose increases don't increase your monthly cost, unlike insurance or other direct-to-consumer services.

PlexusDx Semaglutide vs. Brand-Name Wegovy Pricing

Brand-name Wegovy costs $1,349–$1,549 per month without insurance, and insurance often denies coverage for weight loss alone. PlexusDx's compounded semaglutide injection starts at $149 per month across all three commitment tiers, with no membership fees, no insurance required, and no per-dose markup. You'll never pay more when your dose increases—PlexusDx's flat-rate model is designed for long-term affordability.

Compounded medications from licensed 503A pharmacies have the same active pharmaceutical ingredient (semaglutide) as Wegovy but bypass pharmaceutical markup and insurance gatekeeping. PlexusDx serves all 50 states, accepts HSA and FSA funds, and offers the Precision Peptide Genetic Test ($99 add-on after your first month) to optimize your formula—semaglutide injection alone or combined with tirzepatide in the GLP-Squared formula for maximum personalization.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight do most people lose on semaglutide in the first month?

Most people lose 2–4 pounds in the first month as appetite suppression kicks in and water retention decreases. Significant weight loss accelerates in weeks 4–8. If you're not seeing movement by week 6, PlexusDx can review your compliance and dose with your prescriber to adjust your treatment plan.

Is 15–22% weight loss realistic for everyone?

That range reflects average results from clinical trials, but individual outcomes vary by 5–15% depending on genetics, baseline weight, diet quality, and exercise. PlexusDx's Precision Peptide Genetic Test reveals your predicted response using 49 peptide pathways, helping set personalized goals rather than expecting trial averages.

Will I regain weight if I stop semaglutide?

Most people regain weight within 6–12 months after stopping, as GLP-1 appetite suppression reverses. Some weight loss is permanent due to behavioral changes, but semaglutide works best as long-term therapy. PlexusDx's low starting price ($149/mo) makes ongoing treatment sustainable for many people who would otherwise cycle on and off expensive medications.

Can I combine semaglutide with tirzepatide to lose more weight faster?

PlexusDx offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide for synergistic appetite and blood-sugar control. This is appropriate only if genetic testing shows dual-pathway sensitivity and your prescriber recommends it. GLP-Squared starts at $249/mo and avoids the stacking costs of buying separate medications.

How does the Precision Peptide Genetic Test help predict my weight loss?

The test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that control hunger sensitivity and metabolic rate, mapping 150+ genetic insights across 14 pathways. This predicts whether you'll respond best to semaglutide alone, tirzepatide, or a dual compound—and at what dose range—saving you months of trial-and-error adjustments.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.